Development of Visual Function Evaluation Method (2)

NCT03626207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2024-10-21

No results posted yet for this study

Summary

The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.

Conditions

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Inc

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-04
Primary Completion
2019-06-26
Completion
2019-06-26

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626207 on ClinicalTrials.gov